TRANSCURE BIOSERVICES RAISES €2,5M IN FINANCING
New financing round will enable the company to accelerate its growth and expand its international services offers.
TransCure bioServices (France), a one-stop-shop preclinical services company dedicated to in-vivo full human immune system mouse models, today announced that it has completed a 2.5 million euros funding with Financière Arbevel (France). This financing round will enable the company, healthy and profitable for the last three years, to accelerate its international sales growth as well as to expand in vivo preclinical pharmacology services offers into new product lines in addition to the ongoing full human immune system mouse models for immuno-oncology, inflammation, and infectious diseases, hu-liver and 100% human monoclonal antibody services.
Read the full article and download it below